EXHIBIT ASubscription Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
Exhibit 4.1 Certain portions of this Exhibit have been omitted pursuant to a request for "Confidential Treatment" under Rule 24b-2 of the Securities and Exchange Commission. Such portions have been redacted and bracketed in the request and appear as [...Option Agreement • March 10th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • Delaware
EXHIBIT BRegistration Rights Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
AMENDED AND RESTATED ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • Delaware
INTRODUCTIONShareholder Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • England
ELAN CORPORATION, PLC. ELAN PHARMA INTERNATIONAL LIMITED ELAN INTERNATIONAL SERVICES, LTD. ELAN PHARMACEUTICALS, INC. MONKSLAND HOLDINGS BV AND AMARIN CORPORATION PLC. MASTER AGREEMENT INDEXMaster Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations
EXECUTION COPY EXHIBIT 4.22 SALE AND PURCHASE AGREEMENT THIS SALE AND PURCHASE AGREEMENT (this "Agreement") is made and entered into on March 14, 2003 (the "Effective Date") by and between F.HOFFMANN-LA ROCHE LTD, a Swiss corporation with office at...Sale and Purchase Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations
EXHIBIT 2.6 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
AND CITIBANK, N.A., As Depositary ANDDeposit Agreement • November 28th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations
CONFIDENTIAL Amarin Corporation plcPlacement Agent Agreement • December 17th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
EXHIBIT 4.8 AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT This AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT (this "Agreement"), made the 29th day of March, 2002 ("Effective Date") by and between Eli Lilly and Company, an Indiana corporation...License and Supply Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • Delaware
DEBT SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 17th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 4, 2007, between Amarin Corporation plc, a corporation formed under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
DATED 2003Warrant Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations • England
DEED OF VARIATION RELATING TO AMENDED AND RESTATED DISTRIBUTION, MARKETING AND OPTION AGREEMENT DATED 28 SEPTEMBER 2001 (PERMAX(R))Deed of Variation • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations
DEED OF VARIATION NO. 3 RELATING TO LOAN AGREEMENT DATED 28 SEPTEMBER 2001 AS AMENDEDLoan Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations
AMARIN CORPORATION PLC 7 CURZON STREET LONDON W1J 5HGDeposit Agreement • November 28th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
Reference is made to (i) the Deposit Agreement, dated as of March 29, 1993, as amended by Amendment No. 1 to Deposit Agreement, dated as of October 8, 1998, and as further amended by Amendment No. 2 to Deposit Agreement, dated as of September 25, 2002 (the Deposit Agreement as amended by Amendment No. 1 to Deposit Agreement and Amendment No. 2 to Deposit Agreement, the "Deposit Agreement"), by and among Amarin Corporation plc (formerly known as "Ethical Holdings plc"), a corporation organized and existing under the laws of England and Wales (the "Company"), Citibank, N.A., as Depositary (the "Depositary"), and all Holders from time to time of American Depositary Receipts ("ADRs") evidencing American Depositary Shares ("ADSs") issued thereunder and (ii) the letter agreement, dated as of March 29, 2006 (the "Letter Agreement"), between the Company and the Depositary relating to the issuance of Restricted ADSs (as defined in the Letter Agreement). Capitalized terms used but not defined he
CORSICANTO II DESIGNATED ACTIVITY COMPANY, as Issuer AMARIN CORPORATION PLC, as Guarantor AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee Indenture Dated as of January 25, 2017 3.50% Exchangeable Senior Notes due 2047Indenture • January 25th, 2017 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
INDENTURE, dated as of January 25, 2017 between Corsicanto II Designated Activity Company, a designated activity company incorporated under the laws of Ireland, and having its principal office at Arthur Cox Building, Earlsfort Terrace, Dublin 2, Ireland, D02 CK83, Ireland, as Issuer (the “Issuer”), Amarin Corporation plc, a company incorporated under the laws of England and Wales, and having its principal office at 2 Pembroke House, Upper Pembroke Street 28-32, Dublin 2, Ireland, as Guarantor (the “Guarantor”) and Wilmington Trust, National Association, a national banking association, as Trustee (the “Trustee”).
AMENDED AND RESTATED DEPOSIT AGREEMENT by and among AMARIN CORPORATION PLC AND CITIBANK, N.A., as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES ISSUED HEREUNDER Dated as of November 4, 2011Deposit Agreement • February 29th, 2012 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
AMENDED AND RESTATED DEPOSIT AGREEMENT, dated as of November 4, 2011, by and among (i) Amarin Corporation plc, a company organized under the laws of England and Wales, and its successors (the “Company”), (ii) CITIBANK, N.A., a national banking association organized under the laws of the United States of America acting in its capacity as depositary, and any successor depositary hereunder (the “Depositary”), and (iii) all Holders and Beneficial Owners of American Depositary Shares issued hereunder (all such capitalized terms as hereinafter defined).
SECURITIES SUBSCRIPTION AGREEMENTSecurities Subscription Agreement • March 30th, 2015 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
This SECURITIES SUBSCRIPTION AGREEMENT, dated as of March 30, 2015 (this “Agreement”), is made by and among Amarin Corporation plc, a public limited company incorporated under the laws of England and Wales (the “Company”) and Sofinnova Venture Partners VII, L.P. (“Purchaser”).
As of March 29, 2006 Citibank, N.A. - ADR Department 388 Greenwich Street New York, New York 10013 Restricted ADSs Ladies and Gentlemen: Reference is made to the Deposit Agreement, dated as of March 29, 1993, as amended by Amendment No. 1 to Deposit...Deposit Agreement • November 28th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
ContractEmployment Agreement • December 23rd, 2011 • Amarin Corp Plc\uk • Pharmaceutical preparations • Connecticut
On behalf of Amarin Corporation plc (the “Company”), I am pleased to confirm the terms of your continued employment with the Company, effective January 1, 2012. The purpose of this letter agreement is to set forth those terms of employment. This letter agreement (the “Agreement”) fully supersedes any prior agreements, understanding or arrangements, whether oral or written, implied or express, with respect to the terms and conditions of your employment with the Company including, without limitation, any offer letter, employment agreement or other agreement or understanding relating to compensation, benefits, severance pay or other terms or conditions of employment (collectively, the “Prior Agreements”), provided any agreement you have with the Company and/or any of its subsidiaries or affiliates related to confidentiality/nondisclosure, assignment of inventions and patents, any stock option agreement entered into by you in connection an equity award issued to you by the Company or its s
VARIATION AGREEMENT re: Amended and Restated Assets Purchase Agreement dated 29 September, 1999Variation Agreement • April 24th, 2003 • Amarin Corp Plc\uk • Pharmaceutical preparations
AMARIN CORPORATION PLCLong Term Incentive Award Agreement • July 9th, 2010 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
Amarin Corporation plc 22,222,223 American Depositary Shares Representing 22,222,223 Ordinary Shares (Par Value £0.50 Per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • July 24th, 2019 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
The ADSs are issued pursuant to an Amended and Restated Deposit Agreement dated as of November 4, 2011 (as so amended and supplemented, the “Deposit Agreement”) by and among the Company, Citibank, N.A., as Depositary (the “Depositary”) and all holders and beneficial owners of ADSs issued thereunder.
Belvedere Place BASIC LEASE INFORMATIONLease Agreement • May 9th, 2002 • Amarin Corp Plc\uk • Pharmaceutical preparations • California
API COMMERCIAL SUPPLY AGREEMENT by and between AMARIN PHARMACEUTICALS IRELAND LTD. and CHEMPORT INC. Dated as of May 25, 2011Api Commercial Supply Agreement • March 1st, 2022 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
THIS API COMMERCIAL SUPPLY AGREEMENT (this “Agreement”) is entered into and dated as of the 25th day of May, 2011 (the “Effective Date”) by and between Amarin Pharmaceuticals Ireland Ltd., a corporation organized under the laws of Ireland and having its principal office at First Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4, Ireland (“Amarin”), and Chemport Inc., a corporation organized under the laws of South Korea and having its principal offices at 15-1, Dongsu-dong, Naju-si, Jeollanam-do 520-330 Korea (“Chemport”). Amarin and Chemport are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
September 28, 2007 Amarin Corporation plc First Floor Block 3 The Oval Shelbourne Road Ballsbridge Dublin 4 Amarin Corporation plc - Direct Registration System for ADSs evidenced by Ordinary Shares Ladies and Gentlemen: Reference is made to the...Deposit Agreement • November 28th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
May 26, 2022 Mr. Thomas Reilly Dear Tom:Employment Agreement • August 3rd, 2022 • Amarin Corp Plc\uk • Pharmaceutical preparations • New Jersey
On behalf of Amarin Corporation plc (the “Company”), I am pleased to confirm our offer to employ you as Senior Vice President, Chief Financial Officer. The initial terms and conditions of your employment, should you accept this offer, are set forth below in this letter agreement (the “Agreement”),
ELAN CORPORATION PLC ELAN PHARMA INTERNATIONAL LIMITED ELAN INTERNATIONAL SERVICES, LTD ELAN PHARMACEUTICALS, INC. MONKSLAND HOLDINGS BV AND AMARIN CORPORATION PLCSettlement Agreement • March 31st, 2004 • Amarin Corp Plc\uk • Pharmaceutical preparations • Delaware
MANAGEMENT RIGHTS DEED OF AGREEMENTManagement Rights Deed of Agreement • June 25th, 2010 • Amarin Corp Plc\uk • Pharmaceutical preparations • England and Wales
PREFERRED SHARE DEPOSIT AGREEMENT by and among AMARIN CORPORATION PLC AND CITIBANK, N.A., as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES ISSUED HEREUNDER Dated as of March 30, 2015Preferred Share Deposit Agreement • March 30th, 2015 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
PREFERRED SHARE DEPOSIT AGREEMENT, dated as of March 30, 2015, by and among (i) Amarin Corporation plc, a company organized under the laws of England and Wales, and its successors (the “Company”), (ii) CITIBANK, N.A., a national banking association organized under the laws of the United States of America acting in its capacity as depositary, and any successor depositary hereunder (the “Depositary”), and (iii) all Holders and Beneficial Owners of American Depositary Shares issued hereunder (all such capitalized terms as hereinafter defined).
WITHOUT PREJUDICE & SUBJECT TO CONTRACT UNTIL EXECUTED BY BOTH PARTIES DATED December 10, 2009Compromise Agreement • December 14th, 2009 • Amarin Corp Plc\uk • Pharmaceutical preparations
AMARIN CORPORATION PLC (a non-qualified stock option award)Long Term Incentive Award Agreement • March 16th, 2012 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
This AWARD AGREEMENT (the “Award Agreement”) is entered into and made effective as of March 1, 2012 between Amarin Corporation plc (the “Company”), and Steven B. Ketchum of 49 Canoe Brook Lane, Far Hills, NJ 07931 (“Optionee”), which is intended to operate as an “employees’ share scheme” within Section 1166 of the UK Companies Act 2006. This Option is not being granted under the Amarin Corporation plc 2011 Stock Incentive Plan (the “Plan”). However, capitalized terms used and not defined herein shall have the meanings set forth in the Plan. This Option is not intended to qualify as an “incentive stock option” as defined in Section 422(b) of the Internal Revenue Code of 1986, as amended from time to time (the “Code”). This Option is granted on the terms set out in this Award Agreement.
JOINT FILING AGREEMENTJoint Filing Agreement • April 28th, 2011 • Amarin Corp Plc\uk • Pharmaceutical preparations
The undersigned hereby agree that the Statement on this Schedule 13D, dated April 28, 2011 (the “Schedule 13D”), with respect to the Ordinary Shares, 50 pence par value per share, of Amarin Corporation plc is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13D. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
Dated February 23, 2009 SUPPLY AGREEMENT BETWEEN ANDSupply Agreement • December 4th, 2009 • Amarin Corp Plc\uk • Pharmaceutical preparations
